Jane Street’s NKGen Biotech, Inc. Warrants NKGNW Stock Holding History

Jane Street’s Portfolio NKGNW Stock Details NKGNW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-100,165	Closed	-$10K	–	11048
2024 Q4	$10K	Hold	100,165	–	–	﹤0.01%	9181
2024 Q3	$7.08K	Hold	100,165	–	–	﹤0.01%	9379
2024 Q2	$8.71K	Hold	100,165	–	–	﹤0.01%	9121
2024 Q1	$16K	Hold	100,165	–	–	﹤0.01%	8920
2023 Q4	$8.09K	Hold	100,165	–	–	﹤0.01%	8984
2023 Q3	$39.5K	Hold	100,165	–	–	﹤0.01%	8202
2023 Q2	$20K	Hold	100,165	–	–	﹤0.01%	8360
2023 Q1	$14K	Hold	100,165	–	–	﹤0.01%	8700
2022 Q4	$8.5K	Buy	+100,165	New	+$8.41K	﹤0.01%	8790

Other funds holding NKGNW

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

MTCM

Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 19.06% 1-Year Est. Return

Jane Street's NKGNW Position: Q1 2025 in Review

Jane Street sold out of NKGen Biotech, Inc. Warrants (NKGNW) in Q1 2025, closing a stake of 100,165 shares — an estimated $10K sold.

Jane Street first reported a position in NKGNW in Q4 2022 and held it in 9 quarters. The position peaked at $39.5K in Q3 2023. 3 funds tracked by Wall St. Rank hold NKGNW as of Q1 2025.

Jane Street reported no remaining NKGen Biotech, Inc. Warrants position as of Q1 2025 after selling out during the quarter.
Jane Street sold 100,165 NKGen Biotech, Inc. Warrants shares in Q1 2025, an estimated $10K.
Jane Street first reported a position in NKGen Biotech, Inc. Warrants in Q4 2022 and held it in 9 quarters.
Jane Street's NKGen Biotech, Inc. Warrants position peaked at $39.5K in Q3 2023.
3 funds tracked by Wall St. Rank held NKGen Biotech, Inc. Warrants as of Q1 2025.

Based on Jane Street's 13F filing for Q1 2025, filed 14 May 2025.